← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksREPLRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

REPL logoReplimune Group, Inc. (REPL) Revenue History

Annual and quarterly revenue from 2017 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q3 2026
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

REPL Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

9 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

REPL Revenue Analysis (2017–2025)

As of May 8, 2026, Replimune Group, Inc. (REPL) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2026) recorded $0 in revenue.

Looking at the longer-term picture, REPL's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including AMGN (+9.1% YoY), CGEN (-27.6% YoY), and IOVA (+34.3% YoY). Compare REPL vs AMGN →

REPL Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
REPL logoREPLCurrent$0---
AMGN logoAMGN$36.7B+9.1%+7.6%29.1%
CGEN logoCGEN$28M-27.6%--53.4%
IOVA logoIOVA$264M+34.3%--153.1%
NKTR logoNKTR$55M-43.9%-18.4%-236.8%
Best in groupLowest in group

REPL Historical Revenue Data (2017–2025)

Showing 9 of 9 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$0-$-261,627,000-
2024$0-$0-$-234,773,000-
2023$0-$0-$-177,080,000-
2022$0-$-4,575,000-$-121,484,000-
2021$0-$-4,139,000-$-82,762,000-
2020$0-$0-$-56,198,000-
2019$0-$-148,000-$-30,946,000-
2018$0-$-109,000-$-19,229,000-
2017$0-$-122,000-$-9,647,000-

See REPL's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is REPL Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare REPL vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

REPL — Frequently Asked Questions

Quick answers to the most common questions about buying REPL stock.

Is REPL's revenue growth accelerating or slowing?

REPL TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is REPL's long-term revenue growth rate?

Replimune Group, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is REPL's revenue distributed by segment?

REPL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

REPL Revenue Over Time (2017–2025)